Azotomycin (NSC-56654)--clinical brochure.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001391:Azo Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D002208:Caproates; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004285:Dogs; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental; D051381:Rats
D000903:Antibiotics, Antineoplastic; D001391:Azo Compounds; D002208:Caproates